From the Desk of Steve Strazza and Alfonso Depablos
The first transaction on today’s list comes from a Form 4 filing by Olema Pharmaceuticals Inc $OLMA director Graham Walmsley.
Walmsley reported a purchase of OLMA shares with a total value of $6.8 million.